PALI — PALISADE BIO INC

Ownership history in B Group, Inc.  ·  1 quarter on record

This page tracks every 13F SEC filing in which B Group, Inc. reported a position in PALISADE BIO INC (PALI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
7.81% (2025 Q4)
Avg. % of fund
7.81%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 4,500,000 — — 7.81% $10.6M $2.35
% of Fund (quarterly)    PALI price (monthly, adj. close)

Other funds also holding PALI

As of 2025 Q4 — sorted by position size

Octagon Capital Advisors LP 3Y 2.73% Commodore Capital LP 3Y 1.79% STEMPOINT CAPITAL LP 1.69% Exome Asset Management LLC 0.85% HighVista Strategies LLC 3Y 7Y 0.79% Artia Global Partners LP 3Y 0.66% Eversept Partners, LP 3Y 7Y 0.64% Seven Fleet Capital Management LP 0.59% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.5% SUPERSTRING CAPITAL MANAGEMENT LP 0.46%
← Back to B Group, Inc. Holdings